trilliant health glp-1 prescriptions 2024 GLP-1s Are Reshaping Healthcare, But We Can't Let Cost Outrun Value GLP-1 medications transform bariatric care,

Neurological and Metabolic SupportRegular use may help maintain balanced mood, focus, and efficient metabolism

monitor weekly

These findings are still emerging, and much of the research to date comes from animal and laboratory studies

Key Takeaways Triple agonist mechanism: Retatrutide is the first medication to activate GIP, GLP-1, and glucagon receptors simultaneously GLP-1 component reduces appetite and slows gastric emptying, the core appetite suppression pathway GIP component improves insulin sensitivity and promotes favorable fat distribution Glucagon component increases energy expenditure through thermogenesis and promotes fat breakdown Weight loss: Phase 2 trials showed up to 24.2% weight loss at 48 weeks, compared to tirzepatide (~22%) and semaglutide (~15%) Investigational status: Not FDA-approved